Policy Brief
COVID-19 Manufacturing for Monoclonal Antibodies (Updated August 2020)
Duke-Margolis Authors
Mark McClellan, MD, PhD
Director of the Duke-Margolis Institute for Health Policy
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty